Abstract
An 8 year old girl with primary pulmonary hypertension and signs of heart failure was given 17.5 mg of verapamil injected into the pulmonary artery over 25 minutes to test for the reversibility of pulmonary arteriolar obstruction. Pulmonary artery pressure fell from 70/50 to 35/25 mm Hg. Treatment with 40 mg verapamil by mouth four times daily was started, and she was discharged. She gradually became asymptomatic and resumed the activities of a normal child of school age. On recatheterisation seven months later her pulmonary artery pressure was 30/10 mm Hg. She was still doing well 12 months after the start of treatment.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Camerini F., Alberti E., Klugmann S., Salvi A. Primary pulmonary hypertension: effects of nifedipine. Br Heart J. 1980 Sep;44(3):352–356. doi: 10.1136/hrt.44.3.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Feyter P. J., Kerkkamp H. J., de Jong J. P. Sustained beneficial effect of nifedipine in primary pulmonary hypertension. Am Heart J. 1983 Feb;105(2):333–334. doi: 10.1016/0002-8703(83)90539-2. [DOI] [PubMed] [Google Scholar]
- Farber H. W., Karlinsky J. B., Faling L. J. Fatal outcome following nifedipine for pulmonary hypertension. Chest. 1983 Apr;83(4):708–709. doi: 10.1378/chest.83.4.708. [DOI] [PubMed] [Google Scholar]
- Guazzi M., Olivari M. T., Polese A., Fiorentini C., Magrini F., Moruzzi P. Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):528–532. doi: 10.1002/cpt1977225part1528. [DOI] [PubMed] [Google Scholar]
- Kambara H., Fujimoto K., Wakabayashi A., Kawai C. Primary pulmonary hypertension: beneficial therapy with diltiazem. Am Heart J. 1981 Feb;101(2):230–231. doi: 10.1016/0002-8703(81)90672-4. [DOI] [PubMed] [Google Scholar]
- McMurtry I. F., Davidson A. B., Reeves J. T., Grover R. F. Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs. Circ Res. 1976 Feb;38(2):99–104. doi: 10.1161/01.res.38.2.99. [DOI] [PubMed] [Google Scholar]
- Mélot C., Naeije R., Mols P., Vandenbossche J. L., Denolin H. Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension. Chest. 1983 Feb;83(2):203–207. doi: 10.1378/chest.83.2.203. [DOI] [PubMed] [Google Scholar]
- Wise J. R., Jr Nifedipine in the treatment of primary pulmonary hypertension. Am Heart J. 1983 Apr;105(4):693–694. doi: 10.1016/0002-8703(83)90500-8. [DOI] [PubMed] [Google Scholar]
- Wood B. A., Tortoledo F., Luck J. C., Fennell W. H. Rapid attenuation of response to nifedipine in primary pulmonary hypertension. Chest. 1982 Dec;82(6):793–794. doi: 10.1378/chest.82.6.793. [DOI] [PubMed] [Google Scholar]
- van Breemen C., Mangel A., Fahim M., Meisheri K. Selectivity of calcium antagonistic action in vascular smooth muscle. Am J Cardiol. 1982 Feb 18;49(3):507–510. doi: 10.1016/s0002-9149(82)80003-9. [DOI] [PubMed] [Google Scholar]